-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CBAf/mZMk+FyS3psQq3pUP0D3K94rlfhvE9bmRB2n2zQE9GX9MI80U1VrebhhA9y hSCJmVlT9TxtgsunfpivNQ== 0001193125-04-091665.txt : 20040519 0001193125-04-091665.hdr.sgml : 20040519 20040519160001 ACCESSION NUMBER: 0001193125-04-091665 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040517 ITEM INFORMATION: Other events FILED AS OF DATE: 20040519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUDSON RESPIRATORY CARE INC CENTRAL INDEX KEY: 0001061893 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 951867330 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-56097 FILM NUMBER: 04818743 BUSINESS ADDRESS: STREET 1: 27711 DIAZ RD STREET 2: P O BOX 9020 CITY: TEMECULA STATE: CA ZIP: 92589 BUSINESS PHONE: 9096765611 MAIL ADDRESS: STREET 1: 27711 DIAZ RD STREET 2: P O BOX 9020 CITY: TEMECULA STATE: CA ZIP: 92589 8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) May 17, 2004

 


 

Hudson Respiratory Care, Inc.

(Exact name of registrant as specified in its charter)

 


 

California   333-56097   95-1867330

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

27711 Diaz Road, P.O. Box 9020,

Temecula, California

  92589
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (909)676-5611

 

Not Applicable

(Former name or former address, if changed since last report.)

 



INFORMATION TO BE INCLUDED IN THE REPORT

 

Item 5. Other Events and Regulation FD Disclosure.

 

On May 17, 2004, Teleflex Incorporated, a Delaware corporation (“Teleflex”), TFX Acquisition Corporation, a California corporation and wholly-owned subsidiary of Teleflex (the “Merger Sub”), Freeman Spogli & Co. LLC, FS Equity Partners IV, L.P., a Delaware limited partnership (the “Shareholders’ Representative”), and River Holding Corp., a Delaware corporation (“Holding”) (the Shareholders’ Representative and Holding are collectively referred to as the “Significant Shareholders”), and Hudson Respiratory Care Inc., a California corporation (“Hudson”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). The cash transaction is valued at $460 million, including the retirement of all existing Hudson indebtedness, the redemption of its outstanding preferred stock and the purchase of its outstanding warrants and stock options. Pursuant to the Merger Agreement and subject to the terms and conditions set forth herein, Merger Sub will be merged with and into Hudson (the “Merger”), with Hudson continuing as the surviving corporation. The Merger is subject to approval by the shareholders of Hudson, clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and other customary closing conditions, and is expected to close in the third quarter of 2004.

 

As a condition to Teleflex’s entering into the Merger Agreement, Teleflex has required that certain shareholders of Hudson, including the Significant Shareholders (the “Hudson Shareholders”) enter into a Voting Agreement dated as of May 17, 2004 (the “Voting Agreement”) with Teleflex and Merger Sub. Pursuant to the Voting Agreement, the Hudson Shareholders have agreed to vote all of the shares of Hudson beneficially owned by them in favor of the Merger, the Merger Agreement and the transactions contemplated thereby, provided that Holding’s obligation to do so is contingent upon Holding obtaining the prior approval of its stockholders (The Shareholders’ Representative and its affiliates own more than 75% of Holding’s voting securities).


Item 7. Financial Statements and Exhibits.

 

  (a) Financial Statements of Businesses Acquired.

 

None

 

  (b) Pro Forma Financial Information.

 

None

 

  (c) Exhibits.

 

None


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    HUDSON RESPIRATORY CARE, INC.
    (Registrant)

Date May 18, 2004

 

/s/ Patrick Yount


    (Signature)*
    Patrick Yount
    Chief Financial Officer

* Print name and title of the signing officer under his signature
-----END PRIVACY-ENHANCED MESSAGE-----